21Vianet selected by Alibaba Group as one of its IDC providers to help expand its footprint
BEIJING, Oct. 14, 2019 (GLOBE NEWSWIRE) — 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or the “Company”), a leading carrier- and […]
21Vianet Group, Inc. Announces New Capital Structure Initiative to Enhance the Stability of Its Corporate Structure
BEIJING, Oct. 14, 2019 (GLOBE NEWSWIRE) — 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or the “Company”), a leading carrier- and […]
Immuron North American Q1 Sales Up 111% YoY
Key Highlights:First Quarter of FY2020 (Q1) North American sales grew by 111% YoY to $269K AUDQ1 US Travelan® sales increased […]
ADT Further Expands Mobile Reach with Lyft Partnership
BOCA RATON, Fla., Oct. 14, 2019 (GLOBE NEWSWIRE) — ADT (NYSE: ADT), a leading security and automation provider serving residential […]
Cara Therapeutics Announces Completion of Interim Statistical Assessment and Small Increase in Target Enrollment for KALM-2 Phase 3 Global Trial of KORSUVA™ Injection in Hemodialysis Patients with Pruritus
– Patient enrollment increased approximately 20% to maintain >90% statistical power – – Full trial enrollment expected in fourth quarter of […]
Heritage Commerce Corp Completes Acquisition of Presidio Bank
SAN JOSE, Calif., Oct. 14, 2019 (GLOBE NEWSWIRE) — Heritage Commerce Corp (Nasdaq: HTBK), the holding company (“Heritage” or the […]
Dorman Products, Inc. Announces Date to Report Third Quarter 2019 Financial Results
COLMAR, Pa., Oct. 14, 2019 (GLOBE NEWSWIRE) — Dorman Products, Inc. (NASDAQ:DORM) today announced the Company will report its financial […]
Flexion Therapeutics Announces Extended FDA Review of Supplemental New Drug Application for ZILRETTA®
BURLINGTON, Mass., Oct. 14, 2019 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Food and Drug […]
Matinas BioPharma Initiates EnACT Study of MAT2203 (Oral Amphotericin B) for the Treatment of Fungal Cryptococcal Meningitis
BEDMINSTER, N.J., Oct. 14, 2019 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical stage biopharmaceutical company, […]
Whitestone Announces Non-Core Asset Sales of $39.7 Million
HOUSTON, Oct. 14, 2019 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) continues to execute its strategic […]
